NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Turn Therapeutics Inc.

Turn Therapeutics Inc.

Public
United StatesHealthcarehttps://turntherapeutics.com/

Last Round

Debt

Mar 24, 2026

Est. Valuation

$100.7M

Total Funding Raised

$25M

Company Overview

Turn Therapeutics Inc. is a clinical-stage biotechnology company that develops targeted, non-systemic therapies for inflammatory skin diseases, infectious diseases, and advanced wound care.

Sector

Healthcare

AI Layer

Non-AI

Keywords

drug delivery platformtopical drug deliveryatopic dermatitiseczema treatmenttopical biologicinflammatory skin diseasenon-systemic therapytopical immunomodulatorclinical stage biotechwound carecytokine inhibitorantimicrobial wound dressingIP licensingintranasal vaccinethermostable vaccine

Turn Therapeutics Inc. Comps

Public and private peers based on sector, stage, and business model.

Turn Therapeutics Inc. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Turn Therapeutics Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtMar 24, 2026

Key People

Founding team and executive leadership

Bradley Burnam

Founder Chief Executive Officer

Founding Team

Neil Ghodadra

Board Member And Chief Medical Officer

Executive Team

Turn Therapeutics Inc. Investors

Notable investors and investment history

Turn Therapeutics Inc. investors
InvestorRounds
Avenue Capital GroupDebt

Turn Therapeutics Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Turn Therapeutics Inc. Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersUnited States
Employee Range10
Year Founded2015
Last FundingMar 24, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.